Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes-Reference-Cited by-同舟云学术

Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes

Published:2010-03-12 Issue:4 Volume:88 Page:e107-e114
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:

Author:

Okubo Akiko,Arimura Noboru,Abematsu Noriko,Sakamoto Taiji

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2009.01850.x/fullpdf

Reference30 articles.

1. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy;Akaza;Retina,2008

2. Intravitreal bevacizumab (Avastin) for neovacular age-related macular degeneration;Avery;Ophthalmology,2006

3. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy;Byeon;Acta Ophthalmol,2009

4. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy. One-year results of a prospective case series;Chan;Ophthalmology,2004

5. Tears of the retinal pigment epithelium: an old problem in a new era;Chang;Retina,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical variations of polypoidal choroidal vasculopathy: A cohort study from Japan and the USA;Scientific Reports;2023-03-23

2. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy;PLOS ONE;2022-12-30

3. One year outcomes of treat and extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy;European Journal of Ophthalmology;2021-05-05

4. Clinical Features of Eyes with Polypoidal Choroidal Vasculopathy and No Recurrence Over One Year;Journal of the Korean Ophthalmological Society;2020-09-15

5. Polypoidal Choroidal Vasculopathy: Diagnostic and Therapeutic Considerations;Choroidal Neovascularization;2020